Molika Ashford covers personalized medicine and molecular diagnostics for GenomeWeb.
The University of Washington researchers intend to license the tool, called My46, to other academic and nonprofit research organizations free of charge.
Having sequenced close to 15,000 samples, the project is now taking steps toward integrating results fully into patient medical records.
Results from a study have spurred a new prospective trial comparing arrays, sequencing, and several single-marker assays in men receiving hormonal therapies.
London Health Sciences Center researchers published a study validating the accuracy of the method as a potential screening test for symptomatic male patients.
The Taiwanese research team that developed the method showed in a new study that it could better detect BRAF mutations than conventional PCR plus Sanger sequencing.
If validated further, the 14-gene predictor — associated with aberrant cell division and genome instability — could help avoid overtreatment in low-risk patients, as well as identify those who will respond well to chemotherapy and radiation.
A University of Toronto team developed the probes to improve upon its previously described electrochemical clamp assay technology.
Teneovita will distribute Biocept's test services to hospitals, oncology centers, and individual medical practices throughout the country.
Co-discoverers of the link between the gene EIF2AK4 and specific types of pulmonary hypertension, Intermountain and ARUP are now collaborating to offer clinical testing.
Researchers from both teams plan to continue to refine their findings toward creating simple PCR or other nucleic acid amplification-based assays.
In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.
The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.
The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.
Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."